Evidence map›Paper›PMID 34457116›Full record

ArticleOxidative medicine and cellular longevity2021

Roles of the Immune/Methylation/Autophagy Landscape on Single-Cell Genotypes and Stroke Risk in Breast Cancer Microenvironment.

Jun-Yi Wu, Jun Qin, Lei Li, Kun-Dong Zhang, Yi-Sheng Chen, Yang Li, Tao Jin, Jun-Ming Xu

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jun-Yi Wu *Department of General Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 200080, China.ORCID https://orcid.org/0000-0002-7374-1219
Jun Qin *Department of General Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 200080, China.
Lei LiDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 200080, China.
Kun-Dong ZhangDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 200080, China.
Yi-Sheng ChenDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 200080, China.
Yang LiDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 200080, China.
Tao JinDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 200080, China.ORCID https://orcid.org/0000-0002-8402-2594
Jun-Ming XuDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 200080, China.ORCID https://orcid.org/0000-0002-7446-7493
Shanghai First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study sought to perform integrative analysis of the immune/methylation/autophagy landscape on breast cancer prognosis and single-cell genotypes. Breast Cancer Recurrence Risk Score (BCRRS) and Breast Cancer Prognostic Risk Score (BCPRS) were determined based on 6 prognostic IMAAGs obtained from the TCGA-BRCA cohort. BCRRS and BCPRS, respectively, were used to construct a risk prediction model of overall survival and progression-free survival. Predictive capacity of the model was evaluated using clinical data. Analysis showed that BCRRS is associated with a high risk of stroke. In addition, PPI and drug-ceRNA networks based on differences in BCPRS were constructed. Single cells were genotyped through integrated scRNA-seq of the TNBC samples based on clustering results of BCPRS-related genes. The findings of this study show the potential regulatory effects of IMAAGs on breast cancer tumor microenvironment. High AUCs of 0.856 and 0.842 were obtained for the OS and PFS prognostic models, respectively. scRNA-seq analysis showed high expression levels of adipocytes and adipose tissue macrophages (ATMs) in high BCPRS clusters. Moreover, analysis of ligand-receptor interactions and potential regulatory mechanisms were performed. The LINC00276&MALAT1/miR-206/FZD4-Wnt7b pathway was also identified which may be useful in future research on targets against breast cancer metastasis and recurrence. Neural network-based deep learning models using BCPRS-related genes showed that these genes can be used to map the tumor microenvironment. In summary, analysis of IMAAGs, BCPRS, and BCRRS provides information on the breast cancer microenvironment at both the macro- and microlevels and provides a basis for development of personalized treatment therapy.

Indexed as

AutophagyDNA MethylationBiomarkers, TumorBreast NeoplasmsCombined Modality TherapyFemaleFollow-Up StudiesGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksGenotypeHumansMiddle AgedNeoplasm Recurrence, LocalPrognosisRisk AssessmentBiomarkers, Tumor

Identifiers

PMID34457116
PMCPMC8397558
OpenAlexW3195869677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.